A pilot study to assess utility of changes in elements of the Diabetes Impact Management Scale in evaluating diabetic patients for progressive nephropathy

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 492-496

  Weinrauch, Larry A ^a,b,c,d   Bayliss, George ^b,d   Gleason, Ray E ^d   Lee, Annette T ^e   D'Elia, John A ^a,b,d  

^a JOSLIN DIABETES CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Mt Auburn Hospital   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES IMPACT MANAGEMENT SCALE; DIABETIC NEPHROPATHY; FEMALE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODYNAMIC PARAMETERS; HEMOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION;

ADULT; CASE-CONTROL STUDIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 62349114201     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.005     Document Type: Article

References (21)

1. Aoki T.T., Vlachokosta F.V., Foss M.C., and Meistas M.T. Evidence for restoration of hepatic glucose processing in type I diabetes mellitus. J Clin Invest 71 (1983) 837-839
2. Aoki T.T., Benbarka M.M., Okimura M.C., et al. Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus. Lancet 342 (1993) 525-528
3. Sloan J.A., Aaronson N., Cappelleri J.C., Fairclough D.L., Varricchio C., and the Clinical Significance Consensus Meeting Group. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77 (2002) 479-487
4. De Boer A.G.E.M., van Lanschot J.G.B., Stalmeier P.F.M., van Sandwick J.W., Hulscher J.B.F., deHaes J.C.J.M., et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?. Qual Life Res 13 (2004) 311-320
5. Watkins K., and O'Connell C.M. Measurement of health related QOL in diabetes mellitus. Pharmacoeconomics 17 (2004) 1109-1126
6. Dailey G., Boden G., Creech R., Johnson D., Gleason R.E., Kennedy F.P., et al. Effects of pulsatile intravenous insulin therapy (PIVIT) on the progression of diabetic nephropathy. Metabolism 49 (2000) 1491-1495
7. Aepfelbacher F., Yeon S.B., Weinrauch L.A., D'Elia J., and Burger A.J. Effect of improved glycemic control on left ventricular structure and function in patients with type 1 diabetes mellitus. Int Cardiol 94 (2004) 47-51
8. Weinrauch L.A., Burger A., Gleason R.E., Lee A.T., and D'Elia J.A. Left ventricular mass reduction in type 1 diabetic patients with nephropathy. J Clin Hypertens 7 (2005) 159-164
9. Weinrauch L.A., Burger A., Aronson D., Gleason R.E., Lee A.T., and D'Elia J.A. Regression of left ventricular hypertrophy in diabetic nephropathy: loss of parasympathetic function predicts response to treatment. J Clin Hypertens 8 (2006) 330-335
10. Weinrauch L.A., Burger A.J., Aepfelbacher F., Lee A.T., Gleason R.E., and D'Elia J.A. A pilot study to test the effect of pulsatile insulin infusion on cardiovascular mechanisms that might contribute to attenuation of renal compromise in type 1 diabetic patients with proteinuria. Metabolism 56 (2007) 1453-1457
11. Aoki T.T., and Hammond G.S. Measurement of health status in diabetic patients. Diabetes impact measurement scales. Diabetes Care 15 (1992) 469-477
12. Jacobson A.M., de Groot M., and Samson J.A. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 17 (1994) 267-274
13. McColl E., and Eccles M.P. From the generic to the condition-specific? Instrument order effects in quality of life assessment. Med Care 41 (2003) 777-790
14. Simes R.J., Greatorex V., and Gebski V.J. Practical approaches to minimize problems with missing quality of life data. Stat Med 17 (1998) 725-737
15. Jacobsen P.B., Davis K., and Cella D. Assessing quality of life in research and clinical practice. Oncology 16 (2002) 133-139
16. Mehra S., Tavakaoli M., Kallinikos P.A., Efron N., Boulton A.J.M., Augustine T., et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30 (2007) 2608-2612
17. Parkerson Jr. G.R., Connis R.T., Broadhead W.E., Patrick D.L., Taylor T.R., and Tse C.K. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care 31 (1993) 269-1339
18. Kurella M., Luan J., Lash J.P., and Cherow G.M. A self-assessed sleep quality in chronic kidney disease. Int Urol Nephol 37 (2005) 159-165
19. Chow F.Y., Briganti E.M., Kerr P.G., Chadban S.J., Zimmet P.Z., and Atkins R.C. Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis 41 (2003) 596-604
20. Kusek J.W., Greene P., Wang S.R., Beck G., West D., Jamerson K., et al. Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension Trial. Am J Kidney Dis 39 (2002) 513-524
21. Gorodetskaya I., Zenios S., McCulloch C.E., Bostrom A., Hsu C.Y., Bindman A.B., et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68 (2005) 2801-2808